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Introduction
Henoch-schönlein purpura (HSP), which is predomi-
nantly a disease of childhood, is a small vessel vasculitis.
It is characterized by non-thrombocytopenic purpura,
arthritis and arthralgia, abdominal pain, gastrointestinal
hemorrhage and glomerulonephritis. Prognosis and
treatment opportunities depends on the clinical severity
and organ involvement. Some reports have been pub-
lished suggesting the beneficial effects of plasma
exchange in HSP nephritis, but there have been only
some small case series discussing the efficacy of plasma
exchange in gastrointestinal system (GIS) involvement.
Objectives
The aim of this report is to evaluate the plasma
exchange as a choice for the treatment of life threating
GIS ınvolvement in HSP when refractory to conven-
tional therapies.
Methods
We respectively reviewed the medical records of HSP
patients whom had plasma exchange therapy due to mas-
sive GIS involvement. We reported age, gender, initial
HSP presentation, etiological or triggering factors and
disease course. Treatment modalities, side effects and
their outcomes were noted.
Results
Seven patients who had plasma exchange therapy due to
GIS involvement were identified. All patients had pulse
methylprednisolone (MPZ) treatment and then continued
with oral prednisolone (2mg/kg/day) therapy. All patients’
complaints continued, GI bleeding and the severity of dis-
ease did not improve. Therefore, pulse cyclophosphamide
was added to the treatment. Two patients received intrave-
nous immunoglobulin (IVIG) therapy. Gastrointestinal
manifestations did not improved and plasma exchange
was performed. All patients improved after plasma
exchange management.
Conclusion
Treatment of GI involvement in HSP with plasma
exchange have been mainly based on case reports. Accord-
ing to our data, we propose that, plasma exchange may be
a safe and efficient management choice in pediatric HSP




1Pediatric Nephrology and Rheumatology, Ankara Child Health Hematology
Oncology Education and Research Hospital, Ankara, Turkey. 2Pediatric
Hematology, Ankara Child Health Hematology Oncology Education and
Research Hospital, Ankara, Turkey.
Published: 17 September 2014
doi:10.1186/1546-0096-12-S1-P357
Cite this article as: Basaran et al.: Plasma exchange therapy for severe
gastrointestinal involvement of Henoch Schonlein purpura in children.
Pediatric Rheumatology 2014 12(Suppl 1):P357.
1Pediatric Nephrology and Rheumatology, Ankara Child Health Hematology
Oncology Education and Research Hospital, Ankara, Turkey
Full list of author information is available at the end of the article
Basaran et al. Pediatric Rheumatology 2014, 12(Suppl 1):P357
http://www.ped-rheum.com/content/12/S1/P357
© 2014 Basaran et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
